mGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders.
about
Gluten- and casein-free dietary intervention for autism spectrum conditionsIdentification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.GABAergic signaling as therapeutic target for autism spectrum disordersUse of transcranial magnetic stimulation in autism spectrum disordersTherapeutic Effect of a Synthetic RORα/γ Agonist in an Animal Model of AutismGABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of AutismMetabotropic glutamate receptors in auditory processing.Epilepsy and intellectual disability linked protein Shrm4 interaction with GABABRs shapes inhibitory neurotransmissionMetabotropic Glutamate Receptors: MODULATORS OF CONTEXT-DEPENDENT FEEDING BEHAVIOUR IN C. ELEGANSThe neuropathology of autism.Neurobiological bases of autism-epilepsy comorbidity: a focus on excitation/inhibition imbalance.Sensitivity of the modified Children's Yale-Brown Obsessive Compulsive Scale to detect change: Results from two multi-site trials.Transcranial magnetic stimulation (TMS) therapy for autism: an international consensus conference held in conjunction with the international meeting for autism research on May 13th and 14th, 2014.What Have Proteomic Studies Taught Us About Novel Drug Targets in Autism?Social Skills Deficits in Autism Spectrum Disorder: Potential Biological Origins and Progress in Developing Therapeutic Agents
P2860
Q21129398-DF52DC9C-CA53-4698-9BA3-4F343B4F9276Q26744037-AE2630CB-13E6-4981-98AB-81FADC027F47Q27013583-FEB78A90-78BE-4C17-ABC4-AEC941204C6CQ28300252-1FFCEC00-7DE0-462A-B65B-DDA4910E2860Q28387385-27D4D876-6FE7-4384-8287-624E9979FC8EQ28391720-14C4CCD1-DC9E-4C30-B63F-EC6768A4E791Q30363783-F1C7801B-9877-4CF3-B71A-1012433E8A72Q30841272-54AF77D2-F004-48B6-8906-E0B24E1FE23FQ35721772-76CCF8C8-4027-4C65-8B44-ACCBC6FF0E3AQ37288082-B2C9B668-E0E5-42CA-8867-01416FBB3196Q39269008-FBD7D10F-B907-4A35-BFD6-60871A749117Q41060924-CF91B033-20B8-4B42-B20B-C116432E9893Q42096144-FEF7AAD0-6034-41BF-8BEB-DF8ED78ACC68Q47812079-3E7C7EBD-6339-4546-A0EC-061F6B82F8DCQ58780865-D288C4B8-D3AD-4E2F-98BC-8D1F197D26B3
P2860
mGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
mGluR antagonists and GABA ago ...... of autism spectrum disorders.
@en
type
label
mGluR antagonists and GABA ago ...... of autism spectrum disorders.
@en
prefLabel
mGluR antagonists and GABA ago ...... of autism spectrum disorders.
@en
P2860
P921
P1476
mGluR antagonists and GABA ago ...... of autism spectrum disorders.
@en
P2093
Lindsay M Oberman
P2860
P304
P356
10.1517/13543784.2012.729819
P407
P577
2012-09-26T00:00:00Z